Vivo-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
40
Total Value
755066478
Accession Number
0001213900-25-041737
Form Type
13F-HR
Manager Name
Vivo-Capital
Data Enrichment
98% identified
39 identified1 unidentified

Holdings

40 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
Astria Therapeutics, Inc.
Shares:1.6M
Value:$8.3M
Akero Therapeutics, Inc.
Shares:201.2K
Value:$8.1M
Corvus Pharmaceuticals, Inc.
Shares:2.2M
Value:$7.1M
Compass Therapeutics, Inc.
Shares:3.6M
Value:$6.8M
IO Biotech, Inc.
Shares:6.2M
Value:$6.7M
Cogent Biosciences, Inc.
Shares:1.1M
Value:$6.7M
Unicycive Therapeutics, Inc.
Shares:11.4M
Value:$6.5M
Celcuity Inc.
Shares:610.5K
Value:$6.2M
Rezolute, Inc.
Shares:2.1M
Value:$6.1M
SERA PROGNOSTICS, INC.
Shares:1.7M
Value:$6.1M
Olema Pharmaceuticals, Inc.
Shares:1.5M
Value:$5.7M
Regulus Therapeutics Inc.
Shares:2.7M
Value:$4.7M
Silence Therapeutics plc
Shares:1.1M
Value:$3.1M
Surrozen, Inc./DE
Shares:260.0K
Value:$3.0M
89bio, Inc.
Shares:376.8K
Value:$2.7M
Bolt Biotherapeutics, Inc.
Shares:3.5M
Value:$1.4M
TENAX THERAPEUTICS, INC.
Shares:208.3K
Value:$1.4M
Allakos Inc.
Shares:765.5K
Value:$174.2K
Aligos Therapeutics, Inc.
Shares:10.2K
Value:$84.1K
PRECISION BIOSCIENCES INC
Shares:4.7K
Value:$22.3K